Clinical Social Workers in Hatboro, PA Accepting Medicare

7 Clinical Social Workers found. Showing 1 - 7

Kelly Ann Boettcher, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2355 Karen Ln, Hatboro, PA 19040 Phone: 267-975-8742

Mary Josephine Eidson, LCSW, CCDP Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 24 Drummers Way, Hatboro, PA 19040 Phone: 215-672-4813

Andrea Gahagan, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 101 E Moreland Ave, Hatboro, PA 19040 Phone: 215-622-7736

Mr. Nazareno C Javier, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 52 Saint Dunstans Rd, Hatboro, PA 19040 Phone: 267-221-9382    Fax: 215-956-7155

Mrs. Alexa Briana Gavrilov, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 140 Yorkshire Way, Hatboro, PA 19040 Phone: 267-397-6226

Mrs. Meaghan Fattizzi, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2935 Byberry Rd Ste 108, Hatboro, PA 19040 Phone: 215-957-9771

Julia Spevak, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2935 Byberry Rd Ste 108, Hatboro, PA 19040 Phone: 610-547-4068

News Archive

Research links giftedness to prenatal exposure of testosterone

A longstanding debate as to whether genius is a byproduct of good genes or good environment has an upstart challenger that may take the discussion in an entirely new direction. University of Alberta researcher Marty Mrazik says being bright may be due to an excess level of a natural hormone.

Health institutions tackle high rate of preterm birth

An estimated 15 million babies are born preterm every year and more than one million die within the first 30 days after birth.

Banner MD Anderson Cancer Center to expand its outpatient cancer facility

Banner MD Anderson Cancer Center on the Banner Gateway campus will break ground in January 2013 on an expansion of its outpatient cancer facility, offering a new service and additional equipment and treatment areas to meet the needs of its rapidly growing patient population.

XOMA reaches enrollment goal of 325 patients for Phase 2b clinical trial of XOMA 052

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrollment goal of 325 patients for its Phase 2b dose-ranging clinical trial of XOMA 052, and that it expects patient enrollment to close in July 2010, with top-line results available in the first quarter of 2011. XOMA 052 is a therapeutic antibody candidate that inhibits the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) which drives the inflammatory cause of Type 2 diabetes.

Read more Medical News

› Verified 4 days ago